| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | memantine (Ebixa®) |
| Formulation | 10 mg/g oral drops |
| Reference number | 198 |
| Indication | Treatment of Alzheimer's disease |
| Company | Lundbeck Ltd |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 01/05/2003 |